Royalty Pharma reported 12% growth in Q1 royalty receipts, driven by Vertex, GSK, and Roche. Read why RPRX stock is a Buy.

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we ...